Crown Bioscience Adds BD Managers

Crown Bioscience has appointed two industry veterans to its business development team to support its expansion in the Asia-Pacific region. Crown is a global drug discovery and development services company providing translational platforms to advance oncology and metabolic disease research.
 
Tetsuya Totsuka, Ph.D., was named manager of business development for Japan. Previously, he served as director and chief operating officer of business development for a Tokyo-based biotech firm and director of the original developer of disparity mutagenesis technology, including microorganisms, cultured cells, plants and animals. Totsuka also held key positions with several leading pharmaceutical companies.

Mayet Pantastico was named director of business development for Australia, Singapore, New Zealand and Korea. She has more than 14 years of experience in sales and business development in the pharmaceutical industry, most recently as sales and marketing manager in the Asia-Pacific region for a preclinical CRO focused on oncology models and GLP toxicology studies. She was also business development manager for a preclinical CRO focused on translational models.
 
“Both Mayet and Tetsuya are highly respected professionals with experience in the Asia-Pacific region,” said Laurie Heilmann, senior vice president of global strategy, marketing and business development at Crown Bioscience. “We have seen significant growth in this region, and we are expanding our presence there to meet the demand for our cutting-edge translational platforms and cost-effective drug development solutions for pharmaceutical companies in the region.”